Scott Collins

Scott Collins is a seasoned executive in market access and reimbursement, currently serving as Senior Vice President and Head of Market Access at BridgeBio since September 2021. Prior to this role, Scott was the Senior Vice President of Market Access at QED Therapeutics, leading commercial launches in oncology and rare diseases. Scott's extensive experience includes positions such as Senior Director of Market Access at Pharmacyclics, Senior Director of Reimbursement Operations at Shire Pharmaceuticals, and Associate Director of Reimbursement at Millennium Pharmaceuticals. Scott also has a background in establishing reimbursement strategies as a Reimbursement Manager at Cyberonics and as a Regional Sales Manager at Johnson and Johnson - Ortho Biotech, where notable achievements included recognition as an Infinity Cup and Presidents Cup winner. Scott holds a Bachelor of Science in Business and Organizational Communication from San Francisco State University.